Skip to content

To Investigate the Clinical Efficacy of an Experimental Toothpaste

Clinical Efficacy of an Experimental Toothpaste

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01079910
Enrollment
0
Registered
2010-03-03
Start date
2009-12-09
Completion date
2009-12-10
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Keywords

Plaque, Toothpaste, Gingivitis

Brief summary

The objective of this study is to evaluate the effect of an experimental toothpaste on maintaining gingival health over a 24 week period measured through modified gingival index, bleeding, plaque, and plaque bacteria. Prior to commencing study treatment, subjects will undergo a dental prophylaxis followed by a 2 week period of oral hygiene instruction and weekly professional tooth cleaning to bring the subjects to their optimum gingival health prior to commencing study treatment.

Interventions

DRUGisopropylmethylphenol and Fluoride

0.1% isopropylmethylphenol and 1150ppm fluoride

DRUGFluoride and Silica

NaF/Silica toothpaste containing 1150ppm fluoride

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects aged 18 years and older * A minimum of 20 permanent gradable teeth * For baseline eligibility, subjects must have a minimum Modified Gingival Index score of 1.5-2.3.

Design outcomes

Primary

MeasureTime frame
Change from baseline Modified Gingival Index at 24 weeksbaseline to 24 weeks
Change from baseline Bleeding Index at 24 weeksbaseline to 24 weeks

Secondary

MeasureTime frame
Change from baseline Modified Gingival Index at weeks 6 & 12baseline to week 12
Change from baseline Bleeding Index at weeks 6 & 12baseline to week 12
Change from baseline Plaque Index at weeks 6, 12 & 24baseline to week 24
Change from baseline plaque bacteria at weeks 12 & 24baseline to week 24

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026